Future management of heart failure

The papers in this supplement have been prepared following a symposium entitled “The Future Management of Heart Failure” at the British Cardiac Society annual meeting on 24 May 1999. This session focused on the exciting and compelling new evidence about the role of β blockers in the management of chronic heart failure (CHF). Professor Henry Dargie, chairman of the scientific committee of the second cardiac insufficiency bisoprolol study (CIBIS II), presents an overview of the recent randomised controlled trials with β blockers in CHF, particularly CIBIS II …